|
Volumn 124, Issue 2, 2004, Pages 172-175
|
Selective vestibular ablation by intratympanic gentamicin in patients with unilateral active Ménière's disease: A prospective, double-blind, placebo-controlled, randomized clinical trial
|
Author keywords
Aminoglycosides; Gentamicin; Intratympanic; M ni re's disease; Sensorineural hearing loss; Vertigo treatment
|
Indexed keywords
AMINOGLYCOSIDE ANTIBIOTIC AGENT;
GENTAMICIN;
PLACEBO;
ADULT;
AGED;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE COURSE;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
HUMAN;
INNER EAR;
MALE;
MENIERE DISEASE;
OUTCOMES RESEARCH;
PERCEPTION DEAFNESS;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
VERTIGO;
VESTIBULAR ABLATION;
VESTIBULAR SYSTEM;
ADULT;
AGED;
ANTI-BACTERIAL AGENTS;
AUDIOMETRY, PURE-TONE;
AUDITORY THRESHOLD;
DOUBLE-BLIND METHOD;
EVALUATION STUDIES;
FEMALE;
FOLLOW-UP STUDIES;
GENTAMICINS;
HUMANS;
MALE;
MENIERE'S DISEASE;
MIDDLE AGED;
PROSPECTIVE STUDIES;
|
EID: 1642317904
PISSN: 00016489
EISSN: None
Source Type: Journal
DOI: 10.1080/00016480410016621 Document Type: Article |
Times cited : (74)
|
References (14)
|